IV Infusion/Bolus Pk normalisation [Dissolution / BCS / IVIVC]

posted by pharm07 – India, 2021-06-24 07:48 (415 d 19:35 ago) – Posting: # 22432
Views: 846

» Usually AUC is the parameter you can compare, if you are looking to generate absolute bioavailability details. However, your dose selection depends upon the bioavailability of extravascular administration.
» However, I dont understand the selection of IV lower strength and oral higher strength. Do you have any correlation on data?

Hi, Thanks for your inputs.

To be very specific, if i need to validate the predicted p.o. profile from IV Infusion which is a lower dose than oral, then how to scaleup pk parameter to validate oral predictive profile?

For eg, I have IV infusion 10 mg and i wanted to validate the 80mg oral.

Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]


Complete thread:

UA Flag
 Admin contact
22,301 posts in 4,667 threads, 1,585 registered users;
online 13 (0 registered, 13 guests [including 10 identified bots]).
Forum time: Sunday 03:24 CEST (Europe/Vienna)

No written law has ever been more binding than
unwritten custom supported by popular opinion.    Carrie Chapman Catt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz